Nenghui Wang

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction

Y. Tao, Qiaohong Yang, Xiang Chen, 2020, Nature Communications.

Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors

Sudan N. Loganathan, Jialiang Wang, Nenghui Wang, 2019, Molecular Cancer Therapeutics.

Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction

Y. Tao, Qiaohong Yang, Xiang Chen, 2020, Nature Communications.

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)

J. Iovanna, N. Dusetti, J. Cros, 2019, Front. Oncol..

A novel BET family bromodomain inhibitor NHWD‐870 represents a promising therapeutic agent for a broad spectrum of cancers

Ming-zhu Yin, Q. Yan, Nenghui Wang, 2017 .

Prediction of huge magnetic anisotropy in organometallic molecules

Lei Zhao, Jing-Wen Pang, Yun Zhang, 2017 .